Using previous medication adherence to predict future adherence

Hiraku Kumamaru, Moa P. Lee, Niteesh K. Choudhry, Yaa Hui Dong, Alexis A. Krumme, Nazleen Khan, Gregory Brill, Shun Kosaka, Hiroaki Miyata, Sebastian Schneeweiss, Joshua J. Gagne

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Medication nonadherence is a major public health problem. Identification of patients who are likely to be and not be adherent can guide targeted interventions and improve the design of comparative-effectiveness studies. OBJECTIVE: To evaluate multiple measures of patient previous medication adherence in light of predicting future statin adherence in a large U.S. administrative claims database. METHODS: We identified a cohort of patients newly initiating statins and measured their previous adherence to other chronic preventive medications during a 365-day baseline period, using metrics such as proportion of days covered (PDC), lack of second fills, and number of dispensations. We measured adherence to statins during the year after initiation, defining high adherence as PDC≥80%. We built logistic regression models from different combinations of baseline variables and previous adherence measures to predict high adherence in a random 50% sample and tested their discrimination using concordance statistics (c-statistics) in the other 50%. We also assessed the association between previous adherence and subsequent statin high adherence by fitting a modified Poisson model from all relevant covariates plus previous mean PDC categorized as <25%, 25%-79%, and ≥80%. RESULTS: Among 89,490 statin initiators identified, a prediction model including only demographic variables had a c-statistic of 0.578 (95% CI=0.573-0.584). A model combining information on patient comorbidities, health care services utilization, and medication use resulted in a c-statistic of 0.665 (95% CI=0.659-0.670). Models with each of the previous medication adherence measures as the only explanatory variable yielded c-statistics ranging between 0.533 (95% CI=0.529-0.537) for lack of second fill and 0.666 (95% CI=0.661-0.671) for maximum PDC. Adding mean PDC to the combined model yielded a c-statistic of 0.695 (95% CI=0.690-0.700). Given a sensitivity of 75%, the predictor improved the specificity from 47.7% to 53.6%. Patients with previous mean PDC<25% were half as likely to show high adherence to statins compared with those with previous mean PDC≥80% (risk ratio=0.49, 95% CI=0.46-0.50). CONCLUSIONS: Including measures of previous medication adherence yields better prediction of future statin adherence than usual baseline clinical measures that are typically used in claims-based studies.

Original languageEnglish
Pages (from-to)1146-1155
Number of pages10
JournalJournal of Managed Care and Specialty Pharmacy
Volume24
Issue number11
DOIs
Publication statusPublished - 2018 Nov 1
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Medication Adherence
Statistics
Logistic Models
Patient Acceptance of Health Care
Public health
Medical problems
Health care
Health Services
Logistics
Comorbidity
Public Health
Odds Ratio
Demography
Databases

ASJC Scopus subject areas

  • Pharmacy
  • Pharmaceutical Science
  • Health Policy

Cite this

Kumamaru, H., Lee, M. P., Choudhry, N. K., Dong, Y. H., Krumme, A. A., Khan, N., ... Gagne, J. J. (2018). Using previous medication adherence to predict future adherence. Journal of Managed Care and Specialty Pharmacy, 24(11), 1146-1155. https://doi.org/10.18553/jmcp.2018.24.11.1146

Using previous medication adherence to predict future adherence. / Kumamaru, Hiraku; Lee, Moa P.; Choudhry, Niteesh K.; Dong, Yaa Hui; Krumme, Alexis A.; Khan, Nazleen; Brill, Gregory; Kosaka, Shun; Miyata, Hiroaki; Schneeweiss, Sebastian; Gagne, Joshua J.

In: Journal of Managed Care and Specialty Pharmacy, Vol. 24, No. 11, 01.11.2018, p. 1146-1155.

Research output: Contribution to journalArticle

Kumamaru, H, Lee, MP, Choudhry, NK, Dong, YH, Krumme, AA, Khan, N, Brill, G, Kosaka, S, Miyata, H, Schneeweiss, S & Gagne, JJ 2018, 'Using previous medication adherence to predict future adherence', Journal of Managed Care and Specialty Pharmacy, vol. 24, no. 11, pp. 1146-1155. https://doi.org/10.18553/jmcp.2018.24.11.1146
Kumamaru, Hiraku ; Lee, Moa P. ; Choudhry, Niteesh K. ; Dong, Yaa Hui ; Krumme, Alexis A. ; Khan, Nazleen ; Brill, Gregory ; Kosaka, Shun ; Miyata, Hiroaki ; Schneeweiss, Sebastian ; Gagne, Joshua J. / Using previous medication adherence to predict future adherence. In: Journal of Managed Care and Specialty Pharmacy. 2018 ; Vol. 24, No. 11. pp. 1146-1155.
@article{d4fa48d538234b5f9e94a20e2344ac59,
title = "Using previous medication adherence to predict future adherence",
abstract = "BACKGROUND: Medication nonadherence is a major public health problem. Identification of patients who are likely to be and not be adherent can guide targeted interventions and improve the design of comparative-effectiveness studies. OBJECTIVE: To evaluate multiple measures of patient previous medication adherence in light of predicting future statin adherence in a large U.S. administrative claims database. METHODS: We identified a cohort of patients newly initiating statins and measured their previous adherence to other chronic preventive medications during a 365-day baseline period, using metrics such as proportion of days covered (PDC), lack of second fills, and number of dispensations. We measured adherence to statins during the year after initiation, defining high adherence as PDC≥80{\%}. We built logistic regression models from different combinations of baseline variables and previous adherence measures to predict high adherence in a random 50{\%} sample and tested their discrimination using concordance statistics (c-statistics) in the other 50{\%}. We also assessed the association between previous adherence and subsequent statin high adherence by fitting a modified Poisson model from all relevant covariates plus previous mean PDC categorized as <25{\%}, 25{\%}-79{\%}, and ≥80{\%}. RESULTS: Among 89,490 statin initiators identified, a prediction model including only demographic variables had a c-statistic of 0.578 (95{\%} CI=0.573-0.584). A model combining information on patient comorbidities, health care services utilization, and medication use resulted in a c-statistic of 0.665 (95{\%} CI=0.659-0.670). Models with each of the previous medication adherence measures as the only explanatory variable yielded c-statistics ranging between 0.533 (95{\%} CI=0.529-0.537) for lack of second fill and 0.666 (95{\%} CI=0.661-0.671) for maximum PDC. Adding mean PDC to the combined model yielded a c-statistic of 0.695 (95{\%} CI=0.690-0.700). Given a sensitivity of 75{\%}, the predictor improved the specificity from 47.7{\%} to 53.6{\%}. Patients with previous mean PDC<25{\%} were half as likely to show high adherence to statins compared with those with previous mean PDC≥80{\%} (risk ratio=0.49, 95{\%} CI=0.46-0.50). CONCLUSIONS: Including measures of previous medication adherence yields better prediction of future statin adherence than usual baseline clinical measures that are typically used in claims-based studies.",
author = "Hiraku Kumamaru and Lee, {Moa P.} and Choudhry, {Niteesh K.} and Dong, {Yaa Hui} and Krumme, {Alexis A.} and Nazleen Khan and Gregory Brill and Shun Kosaka and Hiroaki Miyata and Sebastian Schneeweiss and Gagne, {Joshua J.}",
year = "2018",
month = "11",
day = "1",
doi = "10.18553/jmcp.2018.24.11.1146",
language = "English",
volume = "24",
pages = "1146--1155",
journal = "Journal of managed care & specialty pharmacy",
issn = "2376-0540",
publisher = "Academy of Managed Care Pharmacy (AMCP)",
number = "11",

}

TY - JOUR

T1 - Using previous medication adherence to predict future adherence

AU - Kumamaru, Hiraku

AU - Lee, Moa P.

AU - Choudhry, Niteesh K.

AU - Dong, Yaa Hui

AU - Krumme, Alexis A.

AU - Khan, Nazleen

AU - Brill, Gregory

AU - Kosaka, Shun

AU - Miyata, Hiroaki

AU - Schneeweiss, Sebastian

AU - Gagne, Joshua J.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - BACKGROUND: Medication nonadherence is a major public health problem. Identification of patients who are likely to be and not be adherent can guide targeted interventions and improve the design of comparative-effectiveness studies. OBJECTIVE: To evaluate multiple measures of patient previous medication adherence in light of predicting future statin adherence in a large U.S. administrative claims database. METHODS: We identified a cohort of patients newly initiating statins and measured their previous adherence to other chronic preventive medications during a 365-day baseline period, using metrics such as proportion of days covered (PDC), lack of second fills, and number of dispensations. We measured adherence to statins during the year after initiation, defining high adherence as PDC≥80%. We built logistic regression models from different combinations of baseline variables and previous adherence measures to predict high adherence in a random 50% sample and tested their discrimination using concordance statistics (c-statistics) in the other 50%. We also assessed the association between previous adherence and subsequent statin high adherence by fitting a modified Poisson model from all relevant covariates plus previous mean PDC categorized as <25%, 25%-79%, and ≥80%. RESULTS: Among 89,490 statin initiators identified, a prediction model including only demographic variables had a c-statistic of 0.578 (95% CI=0.573-0.584). A model combining information on patient comorbidities, health care services utilization, and medication use resulted in a c-statistic of 0.665 (95% CI=0.659-0.670). Models with each of the previous medication adherence measures as the only explanatory variable yielded c-statistics ranging between 0.533 (95% CI=0.529-0.537) for lack of second fill and 0.666 (95% CI=0.661-0.671) for maximum PDC. Adding mean PDC to the combined model yielded a c-statistic of 0.695 (95% CI=0.690-0.700). Given a sensitivity of 75%, the predictor improved the specificity from 47.7% to 53.6%. Patients with previous mean PDC<25% were half as likely to show high adherence to statins compared with those with previous mean PDC≥80% (risk ratio=0.49, 95% CI=0.46-0.50). CONCLUSIONS: Including measures of previous medication adherence yields better prediction of future statin adherence than usual baseline clinical measures that are typically used in claims-based studies.

AB - BACKGROUND: Medication nonadherence is a major public health problem. Identification of patients who are likely to be and not be adherent can guide targeted interventions and improve the design of comparative-effectiveness studies. OBJECTIVE: To evaluate multiple measures of patient previous medication adherence in light of predicting future statin adherence in a large U.S. administrative claims database. METHODS: We identified a cohort of patients newly initiating statins and measured their previous adherence to other chronic preventive medications during a 365-day baseline period, using metrics such as proportion of days covered (PDC), lack of second fills, and number of dispensations. We measured adherence to statins during the year after initiation, defining high adherence as PDC≥80%. We built logistic regression models from different combinations of baseline variables and previous adherence measures to predict high adherence in a random 50% sample and tested their discrimination using concordance statistics (c-statistics) in the other 50%. We also assessed the association between previous adherence and subsequent statin high adherence by fitting a modified Poisson model from all relevant covariates plus previous mean PDC categorized as <25%, 25%-79%, and ≥80%. RESULTS: Among 89,490 statin initiators identified, a prediction model including only demographic variables had a c-statistic of 0.578 (95% CI=0.573-0.584). A model combining information on patient comorbidities, health care services utilization, and medication use resulted in a c-statistic of 0.665 (95% CI=0.659-0.670). Models with each of the previous medication adherence measures as the only explanatory variable yielded c-statistics ranging between 0.533 (95% CI=0.529-0.537) for lack of second fill and 0.666 (95% CI=0.661-0.671) for maximum PDC. Adding mean PDC to the combined model yielded a c-statistic of 0.695 (95% CI=0.690-0.700). Given a sensitivity of 75%, the predictor improved the specificity from 47.7% to 53.6%. Patients with previous mean PDC<25% were half as likely to show high adherence to statins compared with those with previous mean PDC≥80% (risk ratio=0.49, 95% CI=0.46-0.50). CONCLUSIONS: Including measures of previous medication adherence yields better prediction of future statin adherence than usual baseline clinical measures that are typically used in claims-based studies.

UR - http://www.scopus.com/inward/record.url?scp=85055616140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055616140&partnerID=8YFLogxK

U2 - 10.18553/jmcp.2018.24.11.1146

DO - 10.18553/jmcp.2018.24.11.1146

M3 - Article

VL - 24

SP - 1146

EP - 1155

JO - Journal of managed care & specialty pharmacy

JF - Journal of managed care & specialty pharmacy

SN - 2376-0540

IS - 11

ER -